Nancy Hunter
Impact in
- Oncology top 1%
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- Otorhinolaryngology top 1%
Papers in
- Oncology 41
- Cancer Treatment and Pharmacology 16
- Cancer-related Molecular Pathways 9
- Cancer Cells and Metastasis 8
-
- Effects of Radiation Exposure 28
- Co-authors
- Luka Milas (52 shared papers)L. Milas (21 shared papers)Kathryn A. Mason (25 shared papers)L. Clifton Stephens (12 shared papers)K.A. Mason (6 shared papers)H. Rodney Withers (11 shared papers)Kathy A. Mason (11 shared papers)Luka Milas (16 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (28 papers)Radiation Research (12 papers)Radiotherapy and Oncology (6 papers)Cancer Chemotherapy and Pharmacology (5 papers)Anti-Cancer Drugs (4 papers)
- Partner nations
- United StatesJapanAustralia
In The Last Decade
Nancy Hunter
123 papers receiving 6.6k citations
Peers
Comparison fields: 5 of 135
- Oncology 2.2k
- Otorhinolaryngology 283
- Cancer Research 946
- Radiology, Nuclear Medicine and Imaging 1.0k
- Pulmonary and Respiratory Medicine 1.3k
Countries citing papers authored by Nancy Hunter
This map shows the geographic impact of Nancy Hunter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Hunter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Hunter more than expected).
Fields of papers citing papers by Nancy Hunter
This network shows the impact of papers produced by Nancy Hunter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Hunter. The network helps show where Nancy Hunter may publish in the future.
Co-authors
The 25 scholars most cited alongside Nancy Hunter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 124 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody. | 2000 | 439 |
| 2 | Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate. | 1998 | 297 |
| 3 | Vesico-ureteric reflux and renal scarring. | 1975 | 296 |
| 4 | Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas. | 1999 | 285 |
| 5 | 1996 | 259 | |
| 6 | 2003 | 243 | |
| 7 | Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor. | 2000 | 242 |
| 8 | 1999 | 204 | |
| 9 | 1993 | 188 | |
| 10 | 1978 | 177 | |
| 11 | 1974 | 163 | |
| 12 | 1995 | 160 | |
| 13 | Enhancement of tumor radioresponse in vivo by gemcitabine. | 1999 | 147 |
| 14 | Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes. | 1974 | 141 |
| 15 | 2005 | 139 | |
| 16 | 2004 | 136 | |
| 17 | Docetaxel enhances tumor radioresponse in vivo. | 1997 | 135 |
| 18 | Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel. | 1994 | 114 |
| 19 | Development of apoptosis in irradiated murine tumors as a function of time and dose. | 1993 | 109 |
| 20 | Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors. | 1999 | 107 |
About Nancy Hunter
Nancy Hunter is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 124 papers that have together received 7.0k indexed citations. Recurring topics across this work include Effects of Radiation Exposure (28 papers), Cancer Treatment and Pharmacology (16 papers), Cancer, Hypoxia, and Metabolism (15 papers), Cancer, Stress, Anesthesia, and Immune Response (10 papers), Cell death mechanisms and regulation (9 papers), Cancer-related Molecular Pathways (9 papers), Cancer Research and Treatments (9 papers) and Cancer Cells and Metastasis (8 papers). The work is most often cited by research in Oncology (2.2k citations), Otorhinolaryngology (283 citations), Cancer Research (946 citations), Radiology, Nuclear Medicine and Imaging (1.0k citations) and Pulmonary and Respiratory Medicine (1.3k citations). Nancy Hunter has collaborated with scholars based in United States, Japan and Australia. Frequent co-authors include Luka Milas, L. Milas, Kathryn A. Mason, L. Clifton Stephens, K.A. Mason, H. Rodney Withers, Kathy A. Mason, Luka Milas, Zhen Fan and Raymond E. Meyn. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Radiation Research, Radiotherapy and Oncology, Cancer Chemotherapy and Pharmacology and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.